2025 HCPCS Code Q0169
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
TAGS: therapeutic dosage exceed complete substitute promethazine approved chemotherapy regimen prescription| Short Description | Promethazine hcl 12.5mg oral | 
| HCPCS Action Code | N - No maintenance for this code | 
| HCPCS Coverage Code | D - Special coverage instructions apply | 
| HCPCS Code Added Date | April 01, 1998 | 
| HCPCS Action Effective Date | April 01, 1998 | 
| HCPCS Pricing Indicator Code | 51 - Drugs | 
| HCPCS Type Of Service Code | 1 - Medical care | 
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology | 
| HCPCS Anesthesia Base Unit Quantity | 0 | 
| HCPCS Coverage Issues Manual Reference Section Number | 
Check Similar HCPCS Codes
- Q4184 - Cellesta or duo per sq cm
- Q4185 - Cellesta flowab amnion 0.5cc
- Q4186 - Epifix 1 sq cm
- Q4187 - Epicord 1 sq cm
- Q4188 - Amnioarmor 1 sq cm
- Q4189 - Artacent ac, 1 mg
- Q4190 - Artacent ac 1 sq cm
- Q4191 - Restorigin 1 sq cm
- Q4192 - Restorigin, 1 cc
- Q4193 - Coll-e-derm 1 sq cm
- Q4194 - Novachor 1 sq cm
- Q4195 - Puraply 1 sq cm
- Q4196 - Puraply am 1 sq cm
- Q4197 - Puraply xt 1 sq cm
- Q4198 - Genesis amnio membrane 1sqcm
- Q4199 - Cygnus matrix, per sq cm
- Q4200 - Skin te 1 sq cm
- Q4201 - Matrion 1 sq cm
- Q4202 - Keroxx (2.5g/cc), 1cc
- Q4203 - Derma-gide, 1 sq cm
